About Hopital De La Miletrie; Hematologie Et Oncologie Medicale
Clinical Trials at Hopital De La Miletrie; Hematologie Et Oncologie Medicale
During the past decade, Hopital De La Miletrie; Hematologie Et Oncologie Medicale conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital De La Miletrie; Hematologie Et Oncologie Medicale"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Institut de cancérologie Strasbourg Europe" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Hopital De La Miletrie; Hematologie Et Oncologie Medicale
According to Clinical.Site data, the most researched conditions in "Hopital De La Miletrie; Hematologie Et Oncologie Medicale" are
"B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials), "Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease" (1 trials), "Fit Patients" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Hopital De La Miletrie; Hematologie Et Oncologie Medicale" in a lesser frequency.
Clinical Trials Intervention Types at Hopital De La Miletrie; Hematologie Et Oncologie Medicale
Most popular intervention types in "Hopital De La Miletrie; Hematologie Et Oncologie Medicale" are "Drug" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (3 trials), "Bevacizumab" (2 trials), "Cyclophosphamide" (2 trials), "ACA Continuation" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital De La Miletrie; Hematologie Et Oncologie Medicale
The vast majority of trials in "Hopital De La Miletrie; Hematologie Et Oncologie Medicale" are
10 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hopital De La Miletrie; Hematologie Et Oncologie Medicale
Currently, there are NaN active trials in "Hopital De La Miletrie; Hematologie Et Oncologie Medicale".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hopital De La Miletrie; Hematologie Et Oncologie Medicale,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital De La Miletrie; Hematologie Et Oncologie Medicale, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".